The WVU Heart and Vascular Institute is one of only six centers nationwide now participating in early clinical trials of the Tendyne Mitral Valve System, a mitral valve replacement suitable for patients considered too high-risk for conventional mitral valve surgeries. Vinay Badhwar, MD, WVU HVI executive chair, provides a brief overview of the procedure here.